Global Vaccines Market & Forecast (14 Vaccines Market, Number of People Immunized Doses of Vaccines Administered)

Global Vaccines Market & Forecast (14 Vaccines Market, Number of People Immunized Doses of Vaccines Administered)

  • Renub Research
  • August 2017
  • Vaccines
  • 318 pages

Report Description

1
1

The global market for vaccines is likely to be ruled by the most prominent segments of adult vaccines and pediatric vaccines. The segment of pediatrics vaccines is likely to have a steep rise and double in size as compared to the segment of adult vaccines. However, the number of infants immunized is likely to comparatively low by the end of 2017 than the number of adults who have been immunized. The number of doses of Rotavirus being administered in infants is likely to take a shot by the end of 2022 and reach almost 15 million by the end of the same year.

The global market for vaccines is also expected to witness extensive progress owing to the growing prevalence of infectious diseases across the globe and the rising focus of developing as well as developed countries on immunization programs. However, the market might face roadblocks owing to the expensive nature of some vaccines and inadequate access to certain vaccines.

Global Vaccines Market to reach US$ 60 Billion by the year 2022. Pediatric vaccines market is having a dominant market share compared to Adult vaccines market. By 2022 Pediatric vaccines market share will be double the size of adult vaccines market share. Worldwide the number of infants immunized by influenza vaccines remain considerably low than that of adults immunized in year 2017. While the number of Rotavirus doses administered in infants is forecast to increase over the years and reach nearly 15 Million by the year 2022.       

Adult Vaccine Market Share Analysis

Out of the total 9 Adult vaccines (Influenza, Cervical Cancer, Zoster, MMRV, Pneumococcal, Meningococcal, Hepatitis, TdaP, Travel) studied in the report Influenza vaccines dominates the adult vaccine market in 2017.

Pediatric Vaccine Market Share Analysis

Our analysis found that in year 2017; Pneumococcal and Combination vaccine together accounts for nearly 50% of the pediatric vaccine market share. Other Pediatric vaccines market studied in the report are as follows: Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Haemophilus Influenzae Type b(Hib), Combos, Polio, Rotavirus, Varicella.

In 2017 Combos Vaccines will control the Immunization Share

For the year 2017; Combos (Combination Vaccines) has the maximum immunization share among all pediatric vaccines (Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Haemophilus Influenzae Type b(Hib), Polio, Rotavirus, Varicella) studied in the report as they protect against more ailments in single shot, people preferring to get combination vaccine instead of a specific vaccine.

Administration of Vaccine Doses

Our analysis found that there is a consistent surge in the number of Pneumococcal and Meningococcal vaccine doses administration in future due to the rising concern against the life-threatening vaccine-preventable diseases around the world.

Global Vaccines Market & Forecast (14 Vaccines Market, Number of People Immunized  Doses of Vaccines Administered) is the 8th edition of market research report published by Renub Research on Global Vaccines Market. This is a 318 page report with 193 Figures and 44 Tables provides data of Global Vaccine Market (Adult & Pediatrics), People Immunized, Number of Vaccine Doses Administered (Disease wise) & Key Players. Vaccine has been extensively studied from 3 major points, and further sub-divided into 2 more points:    

  1. World Vaccines (Disease wise) Market & Forecast (2011 – 2022)
  2. Adult Vaccines Market & Forecast
  3. Pediatrics Vaccines Market & Forecast
  4. People Immunized (Disease wise) & Forecast (2011 – 2022)
  5. Adult Immunized & Forecast
  6. Pediatric (Infants) Immunized & Forecast
  7. Doses of Vaccines Administered (Disease wise) & Forecast (2011 – 2022)
  8. Doses of vaccines administered in Adults & Forecast 
  9. Doses of vaccines administered in Pediatric (Infants) & Forecast 

14 Vaccines Studied in the Report are as Follows:

  • Influenza
  • Cervical Cancer
  • Zoster (Shingles)
  • MMR (Measles, Mumps, and Rubella)
  • Pneumonia
  • Meningitis
  • Hepatitis
  • Tap (Diphtheria, Tetanus, Pertussis)
  • Haemophilus influenzae type B
  • Polio
  • Rotavirus
  • Varicella
  • Combination Vaccine
  • Travel & Miscellaneous Vaccine

Why This Report a Compulsory Buy!

  • This report offers complete analysis of Disease wise Global Vaccines Market & Forecast (2011 – 2022).
  • This report offers segmented analysis of Disease wise Global Vaccines Market into two segments:
  • Adult Vaccines (Disease wise) Market &Forecast
  • Pediatric (Infant) Vaccines (Disease wise) Market &Forecast
  • This report offers extensive analysis of the number of people Immunized and Number of Vaccines Doses Administered & Forecast (2011 – 2022) by Adult & Pediatric (Infant).
  • This report offers widespread analysis on Vaccine Key Players (Worldwide) & Forecast (2011 – 2022)

Have query on this report?

Make an Enquiry

Table of Content

1. Research Findings

2. Global – Vaccines Market and Forecast

2.1 Adult Vaccines Market and Forecast
2.2 Pediatric (Infant) Vaccines Market and Forecast

3. Global – Adult Vaccine vs. Pediatric Vaccine Market Share

4. Global – Vaccines Market Share and Forecast

4.1 Adult Vaccines Market Share and Forecast
4.2 Pediatric (Infant) Vaccines Market Share and Forecast

5. Global – People Immunized and Forecast
5.1 Adult Immunized and Forecast
5.2 Pediatric (Infant) Immunized and Forecast

6. Global – People Immunized Share and Forecast
6.1 Adult Immunized Share and Forecast
6.2 Pediatric (Infant) Immunized Share and Forecast

7. Global – Doses of Vaccines Administered and Forecast
7.1 Doses of Adult Vaccines Administered and Forecast
7.2 Doses of Pediatric (Infant) Vaccines Administered and Forecast

Table 2?1: Vaccine Recommendations
Table 2?2: Other Recommended Vaccines
Table 4?1: Global – Vaccines Market Share (Percent), 2011 - 2016
Table 4?2: Global – Forecast for Vaccines Market Share (Percent), 2017 - 2022
Table 4?3: Global – Adult Vaccines Market Share (Percent), 2011 - 2016
Table 4?4: Global – Adult Vaccines Market Share (Percent), 2017 - 2022
Table 4?5: Global – Pediatric (Infant) Vaccines Market Share (Percent), 2011 - 2016
Table 4?6: Global – Forecast for Pediatric (Infant) Vaccines Market Share (Percent), 2017 - 2022
Table 6?1: Global – People Immunized Share (Percent), 2011 - 2016
Table 6?2: Global – Forecast for People Immunized Share (Percent), 2017 – 2022
Table 6?3: Global – Adult Immunized Share (Percent), 2011 - 2016
Table 6?4: Global – Forecast for Adult Immunized Share (Percent), 2017 – 2022
Table 6?5: Global – Pediatric (Infant) Immunized Share (Percent), 2011 – 2016
Table 6?6: Global – Forecast for Pediatric (Infant) Immunized Share (Percent), 2017 – 2022
Table 8?1: Global – Doses of Vaccines Administered Share (Percent), 2011 - 2016
Table 8?2: Global – Forecast for Doses of Vaccines Administered Share (Percent), 2017 - 2022
Table 8?3: Global – Doses of Vaccines Administered to Adult Share (Percent), 2011 - 2016
Table 8?4: Global – Forecast for Doses of Vaccines Administered to Adult Share (Percent), 2017 - 2022
Table 8?5: Global – Doses of Vaccines Administered to Pediatric (Infant) Share (Percent), 2011 - 2016
Table 8?6: Global – Forecast for Doses of Vaccines Administered to Pediatric (Infant) Share (Percent), 2017 - 2022
Table 13?1: Vaccines – Number of Reported Cases, 2011 – 2015
Table 13?2: Measles – Number of Cases Reported, 2001 – 2015
Table 13?3: Mumps – Number of Cases Reported, 2001 - 2015
Table 13?4: Rubella – Number of Cases Reported, 2001 - 2015
Table 13?5: Rubella (CRS) – Number of Cases Reported, 2001 - 2015
Table 13?6: Diphtheria – Number of Cases Reported, 2001 - 2015
Table 13?7: Tetanus (Neonatal) – Number of Cases Reported, 2001 – 2015
Table 13?8: Tetanus (Total) – Number of Cases Reported, 2001 - 2015
Table 13?9: Pertussis – Number of Cases Reported, 2001 - 2015
Table 13?10: Polio – Number of Cases Reported, 2001 - 2015
Table 13?11: Yellow Fever – Number of Cases Reported, 2001 - 2015
Table 13?12: Japanese Encephalitis – Number of Cases Reported, 2006 - 2015
Table 15?1: Merck Vaccine Product Pipeline
Table 15?2: Sanofi Vaccine Product Pipeline
Table 15?3: Pfizer Vaccine Product Pipeline
Table 16?1: Vaccine Mergers & Acquisitions
Table 18?1: United States Immunization Schedule
Table 18?2: Afghanistan Immunization Schedule
Table 18?3: Norway Immunization Schedule
Table 18?4: India Immunization Schedule
Table 18?5: Vietnam Immunization Schedule
Table 18?6: Worldwide – Total Future Deaths Averted through Vaccination (Million), 2011 – 2020
Table 18?7: Goal-Level Indicators, 2015 & 2020
Table 18?8: Improvement Strategies or Requirements – the Joint Commission and the Project’s Collaborating Organizations

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074